Contraindicated. Coadministration of doravirine with a robust CYP3A inducer may minimize doravirine plasma concentrations and/or effects. Opportunity for lack of virologic reaction and doable resistance to doravirine.pentobarbital will lessen the extent or influence of lonafarnib by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindic